Table 5.

Effect of probable streptococcal infection – results for participants with a Centor scorea of ≥3 according to antibiotic strategy

Antibiotic prescribing strategyPoorer global symptomatic outcome, n (%)Interaction term (95% CI), P-valueUnivariate risk ratio (95% CI), P-valueRisk ratio controlling for baseline severity and clustering (95% CI), P-valueRisk ratio controlling for propensity score (95% CI), P-valueRisk ratio controlling for propensity score in imputed dataset (95% CI), P-value
None (reference)
n= 33
23 (69.7)1.001.001.001.00
Immediate
n= 374
207 (55.3)0.88 (0.68 to 1.14), P = 0.3450.79 (0.62 to 1.01), P = 0.0630.79 (0.62 to 1.00), P = 0.0510.79 (0.63 to 1.00), P = 0.0460.82 (0.65 to 1.03), P = 0.097
Delayed
n= 43
21 (48.8)0.83 (0.55 to 1.23), P = 0.3490.70 (0.48 to 1.02), P = 0.0660.72 (0.49 to 1.06), P = 0.0960.64 (0.45 to 0.92), P = 0.0150.65 (0.45 to 0.94), P = 0.021
  • a Centor score: 1 point for each of tonsillar exudates, swollen tender anterior cervical nodes, lack of a cough, and history of fever.